Suiyi Wu

590 total citations · 1 hit paper
16 papers, 294 citations indexed

About

Suiyi Wu is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Suiyi Wu has authored 16 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Biomedical Engineering. Recurrent topics in Suiyi Wu's work include Ultrasound and Hyperthermia Applications (4 papers), RNA modifications and cancer (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). Suiyi Wu is often cited by papers focused on Ultrasound and Hyperthermia Applications (4 papers), RNA modifications and cancer (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). Suiyi Wu collaborates with scholars based in China, Ethiopia and United States. Suiyi Wu's co-authors include Jia Fan, Bo Hu, Xin‐Rong Yang, Ximing Xu, Yang Xu, Yilin Yang, Xianzhao Wei, Jianwen Cheng, Pengxiang Wang and Ming Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Suiyi Wu

16 papers receiving 290 citations

Hit Papers

Targeting SRSF10 might inhibit M2 macrophage polarization... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suiyi Wu China 11 124 80 79 46 44 16 294
Shi‐Jun Xu China 10 147 1.2× 85 1.1× 31 0.4× 40 0.9× 40 0.9× 27 307
Fei Yin China 11 115 0.9× 46 0.6× 83 1.1× 18 0.4× 51 1.2× 28 265
Zhipeng Cao Australia 7 110 0.9× 61 0.8× 48 0.6× 28 0.6× 33 0.8× 17 247
Yu-Kai Su Taiwan 10 162 1.3× 85 1.1× 94 1.2× 43 0.9× 15 0.3× 14 340
Ji Ma China 9 98 0.8× 71 0.9× 52 0.7× 35 0.8× 11 0.3× 30 277
Weimin Wu China 11 169 1.4× 103 1.3× 59 0.7× 57 1.2× 19 0.4× 19 326
Kah Yong Goh United States 8 220 1.8× 38 0.5× 30 0.4× 34 0.7× 16 0.4× 8 319
Ilario Giovanni Rapposelli Italy 9 115 0.9× 44 0.6× 129 1.6× 26 0.6× 10 0.2× 30 258
Shipeng Dai China 10 100 0.8× 59 0.7× 37 0.5× 31 0.7× 8 0.2× 17 229
Mark Kalinich United States 8 57 0.5× 76 0.9× 171 2.2× 23 0.5× 12 0.3× 15 303

Countries citing papers authored by Suiyi Wu

Since Specialization
Citations

This map shows the geographic impact of Suiyi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suiyi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suiyi Wu more than expected).

Fields of papers citing papers by Suiyi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suiyi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suiyi Wu. The network helps show where Suiyi Wu may publish in the future.

Co-authorship network of co-authors of Suiyi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Suiyi Wu. A scholar is included among the top collaborators of Suiyi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suiyi Wu. Suiyi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wu, Suiyi, Yuanyuan Zhu, Jialei Sun, et al.. (2025). Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation. Nature Communications. 16(1). 10039–10039. 1 indexed citations
2.
Zhang, Feng, Suiyi Wu, Gui‐Qi Zhu, et al.. (2024). Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma. Cancer Communications. 44(11). 1231–1260. 71 indexed citations breakdown →
3.
Yang, Xin‐Rong, Jian‐Wen Cheng, Suiyi Wu, et al.. (2023). The efficacy and safety of toripalimab combined with sorafenib for unresectable hepatocellular carcinoma: An open-label, prospective, single-arm phase II study.. Journal of Clinical Oncology. 41(16_suppl). e16184–e16184. 3 indexed citations
4.
Cai, Jialiang, Suiyi Wu, Feng Zhang, & Zhi Dai. (2022). Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma. Frontiers in Immunology. 13. 952413–952413. 4 indexed citations
5.
Song, Fei, Feiyu Chen, Suiyi Wu, et al.. (2021). Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinoma. Journal of Cancer. 12(23). 6937–6947. 15 indexed citations
6.
Wang, Pengxiang, Yun‐Fan Sun, Jianwen Cheng, et al.. (2020). Circulating tumor cell detection and single‐cell analysis using an integrated workflow based on ChimeraX®‐i120 Platform: A prospective study. Molecular Oncology. 15(9). 2345–2362. 14 indexed citations
7.
Hu, Bo, Yang Xu, Yuancheng Li, et al.. (2020). CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1‐NF‐κB oncogenic signaling. SHILAP Revista de lepidopterología. 10(8). e233–e233. 69 indexed citations
8.
Xu, Yang, Yun‐Fan Sun, Jian‐Wen Cheng, et al.. (2020). Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation. Liver International. 41(3). 562–573. 37 indexed citations
9.
Wu, Suiyi, Ximing Xu, Jingchuan Sun, et al.. (2018). Low‐Intensity Pulsed Ultrasound Accelerates Traumatic Vertebral Fracture Healing by Coupling Proliferation of Type H Microvessels. Journal of Ultrasound in Medicine. 37(7). 1733–1742. 12 indexed citations
10.
11.
Wu, Suiyi, Ximing Xu, Yao Zhang, et al.. (2018). Occurrence of substance�P and neurokinin receptors during the early phase of spinal fusion. Molecular Medicine Reports. 17(5). 6691–6696. 2 indexed citations
12.
Zhou, Xiaoyi, Ximing Xu, Fei Wang, et al.. (2017). Cross-cultural validation of simplified Chinese version of spine functional index. Health and Quality of Life Outcomes. 15(1). 203–203. 10 indexed citations
13.
Zhou, Xiaoyi, Ximing Xu, Fei Wang, et al.. (2017). Validations and psychological properties of a simplified Chinese version of pain anxiety symptoms scale (SC-PASS). Medicine. 96(10). e5626–e5626. 16 indexed citations
14.
Zhou, Xiaoyi, Ximing Xu, Suiyi Wu, et al.. (2017). Low-Intensity Pulsed Ultrasound-Induced Spinal Fusion is Coupled with Enhanced Calcitonin Gene-Related Peptide Expression in Rat Model. Ultrasound in Medicine & Biology. 43(7). 1486–1493. 10 indexed citations
15.
Zhou, Xiaoyi, Suiyi Wu, Zicheng Zhang, et al.. (2017). Low-intensity pulsed ultrasound promotes endothelial cell-mediated osteogenesis in a conditioned medium coculture system with osteoblasts. Medicine. 96(43). e8397–e8397. 11 indexed citations
16.
Zhou, Xiaoyi, Ximing Xu, Suiyi Wu, et al.. (2016). Spatiotemporal Changes of Calcitonin Gene-Related Peptide Innervation in Spinal Fusion. BioMed Research International. 2016. 1–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026